Health Discovery Challenges Intel Patent on Method with Genetic Applications | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Health Discovery Corporation today announced it has filed a request for the reexamination of a patent held by Intel with applications for the identification of disease genes.

The request to the US Patent and Trademark Office challenges US Patent No. 7,685,077, which grants Intel the rights to the RFE-SVM method as described in the patent entitled, "Recursive Feature Eliminating Method Based on a Support Vector Machine."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.